Literature DB >> 28163103

Optimizing antibody expression: The nuts and bolts.

B Vijayalakshmi Ayyar1, Sushrut Arora2, Shiva Shankar Ravi1.   

Abstract

Antibodies are extensively utilized entities in biomedical research, and in the development of diagnostics and therapeutics. Many of these applications require high amounts of antibodies. However, meeting this ever-increasing demand of antibodies in the global market is one of the outstanding challenges. The need to maintain a balance between demand and supply of antibodies has led the researchers to discover better means and methods for optimizing their expression. These strategies aim to increase the volumetric productivity of the antibodies along with the reduction of associated manufacturing costs. Recent years have witnessed major advances in recombinant protein technology, owing to the introduction of novel cloning strategies, gene manipulation techniques, and an array of cell and vector engineering techniques, together with the progress in fermentation technologies. These innovations were also highly beneficial for antibody expression. Antibody expression depends upon the complex interplay of multiple factors that may require fine tuning at diverse levels to achieve maximum yields. However, each antibody is unique and requires individual consideration and customization for optimizing the associated expression parameters. This review provides a comprehensive overview of several state-of-the-art approaches, such as host selection, strain engineering, codon optimization, gene optimization, vector modification and process optimization that are deemed suitable for enhancing antibody expression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Keywords:  Antibody expression; Codon optimization; Expression hosts; Gene optimization; Process optimization; Vector modification

Mesh:

Substances:

Year:  2017        PMID: 28163103     DOI: 10.1016/j.ymeth.2017.01.009

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  7 in total

Review 1.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

2.  Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.

Authors:  Yongxiao Yang; Zhengmei Li; Qin Li; Kai Ma; Yan Lin; Huigen Feng; Tianyun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-07-05       Impact factor: 5.560

3.  Genomic integration and ligand-dependent activation of the human estrogen receptor α in the crustacean Daphnia magna.

Authors:  Kerstin Törner; Tsuyoshi Nakanishi; Tomoaki Matsuura; Yasuhiko Kato; Hajime Watanabe
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

4.  Screening Antibody Libraries with Colony Assay Using scFv-Alkaline Phosphatase Fusion Proteins.

Authors:  Yoshiro Hanyu; Mieko Kato
Journal:  Molecules       Date:  2020-06-24       Impact factor: 4.411

Review 5.  Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells.

Authors:  Jun-He Zhang; Lin-Lin Shan; Fan Liang; Chen-Yang Du; Jing-Jing Li
Journal:  Front Bioeng Biotechnol       Date:  2022-03-04

6.  Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm.

Authors:  İlkay Koçer; Emily C Cox; Matthew P DeLisa; Eda Çelik
Journal:  Biotechnol Prog       Date:  2020-11-20

7.  A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.

Authors:  Md Kausar Alam; Michelle Brabant; Raja Solomon Viswas; Kris Barreto; Humphrey Fonge; C Ronald Geyer
Journal:  BMC Biotechnol       Date:  2018-09-10       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.